Evolutions of the Management of Colorectal Cancer Liver Metastasis: A Bibliometric Analysis

被引:10
作者
Jin, Bao
Wu, Xiang'an
Xu, Gang
Xing, Jiali
Wang, Yuxin
Yang, Huayu
Du, Shunda
Mao, Yilei
机构
[1] Peking Union Med Coll PUMC, Peking Union Med Coll Hosp PUMCH, Dept Liver Surg, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci CAMS, Beijing 100730, Peoples R China
来源
JOURNAL OF CANCER | 2021年 / 12卷 / 12期
基金
中国国家自然科学基金;
关键词
colorectal cancer liver metastasis (CRCLM); bibliometric analysis; therapy; management; citation; CLINICAL-PRACTICE GUIDELINES; BODY RADIATION-THERAPY; RESECTION; TRIAL;
D O I
10.7150/jca.52842
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Tremendous progress has been made in the treatment of colorectal cancer liver metastasis (CRCLM) in recent decades, and thousands of papers have been published. Therefore, we conducted a bibliometric analysis of articles related to CRCLM treatment to explore its evolution. Materials and Methods: The Clarivate Analytics Web of Science (WOS) Core Collection database was searched through June 2020 using terms related to CRCLM treatment. We analyzed the bibliographic information of the literature related to CRCLM treatment and explored the research topics to understand its evolution over time. Results: We identified 3436 records related to CRCLM treatment in the WOS database. The total number of times these documents were cited ranged 0-2352, and the years of publication spanned 1976-2020. The greatest numbers of articles were published in the United States, Japan, and France. Among institutions, Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, and Oslo University Hospital published the most articles. Regarding authors, Jarnagin WR, Adam R, Vauthey JN published the most articles. The research topics of these articles included systemic chemotherapy, molecular targeted therapy, the outcome of liver resection, prognosis prediction, hepatic artery infusion, radiofrequency ablation, and two-stage hepatectomy. Conclusion: Bibliometric analysis of studies related to CRCLM treatment can help doctors and researchers quickly understand the development trend in this field. These data emphasize the current management of patients with CRCLM, and they can potentially guide the direction of future research.
引用
收藏
页码:3660 / 3670
页数:11
相关论文
共 47 条
  • [1] Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review)
    Al Bandar, Mahdi Hussain
    Nam Kyu Kim
    [J]. ONCOLOGY REPORTS, 2017, 37 (05) : 2553 - 2564
  • [2] bibliometrix: An R-tool for comprehensive science mapping analysis
    Aria, Massimo
    Cuccurullo, Corrado
    [J]. JOURNAL OF INFORMETRICS, 2017, 11 (04) : 959 - 975
  • [3] The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases
    Balacescu, Ovidiu
    Sur, Daniel
    Cainap, Calin
    Visan, Simona
    Cruceriu, Daniel
    Manzat-Saplacan, Roberta
    Muresan, Mihai-Stefan
    Balacescu, Loredana
    Lisencu, Cosmin
    Irimie, Alexandru
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [4] International publication trends in dry eye disease research: A bibliometric analysis
    Boudry, Christophe
    Baudouin, Christophe
    Mouriaux, Frederic
    [J]. OCULAR SURFACE, 2018, 16 (01) : 173 - 179
  • [5] Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Cervantes, A.
    Adam, R.
    Rosello, S.
    Arnold, D.
    Normanno, N.
    Taieb, J.
    Seligmann, J.
    De Baere, T.
    Osterlund, P.
    Yoshino, T.
    Martinelli, E.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 (01) : 10 - 32
  • [6] Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review
    Datta, Jashodeep
    Narayan, Raja R.
    Kemeny, Nancy E.
    D'Angelica, Michael, I
    [J]. JAMA SURGERY, 2019, 154 (08) : 768 - 776
  • [7] Colorectal cancer
    Dekker, Evelien
    Tanis, Pieter J.
    Vleugels, Jasper L. A.
    Kasi, Pashtoon M.
    Wallace, Michael B.
    [J]. LANCET, 2019, 394 (10207) : 1467 - 1480
  • [8] Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab
    Dohan, Anthony
    Gallix, Benoit
    Guiu, Boris
    Le Malicot, Karine
    Reinhold, Caroline
    Soyer, Philippe
    Bennouna, Jaafar
    Ghiringhelli, Francois
    Barbier, Emilie
    Boige, Valerie
    Taieb, Julien
    Bouche, Olivier
    Francois, Eric
    Phelip, Jean-Marc
    Borel, Christian
    Faroux, Roger
    Seitz, Jean-Francois
    Jacquot, Stephane
    Ben Abdelghani, Meher
    Khemissa-Akouz, Faiza
    Genet, Dominique
    Jouve, Jean Louis
    Rinaldi, Yves
    Desseigne, Francoise
    Texereau, Patrick
    Suc, Etienne
    Lepage, Come
    Aparicio, Thomas
    Hoeffel, Christine
    [J]. GUT, 2020, 69 (03) : 531 - 539
  • [9] Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases
    Fong, Y
    Fortner, J
    Sun, RL
    Brennan, MF
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 1999, 230 (03) : 309 - 318
  • [10] Predicting prognosis in colorectal liver metastases
    Grunhagen, Dirk
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (06) : 643 - 645